FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS
    2.
    发明申请
    FAMILY OF ARYL, HETEROARYL, O-ARYL AND O-HETEROARYL CARBASUGARS 有权
    ARYL,HETEROARYL,O-ARYL和O-HETEROARYL CARBASUGARS家族

    公开(公告)号:US20140105839A1

    公开(公告)日:2014-04-17

    申请号:US14119265

    申请日:2012-05-29

    摘要: The present invention relates to a compound of the following formula (I): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as SGLT1, SGLT2 and SGLT3, in particular in the treatment or prevention of diabetes, and more particularly type-II diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, X syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti-inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin.

    摘要翻译: 本发明涉及以下式(I)的化合物及其制备方法,包含其的药物和化妆品组合物及其用途,特别是作为钠依赖型葡萄糖共转运体的抑制剂,例如SGLT1 特别是糖尿病的治疗或预防,特别是II型糖尿病,糖尿病相关并发症如下肢关节炎,心肌梗塞,肾功能不全,神经病变或失明,高血糖症,高胰岛素血症, 肥胖症,高甘油三酯血症,X综合征和动脉硬化,以及其用作抗癌,抗感染,抗病毒,抗血栓形成或抗炎药物,或用于减轻,漂白,脱色皮肤,从 皮肤,特别是老年斑和雀斑,或防止皮肤色素沉着。

    GEM-DIFLUORINATED C-ISOPROPYLGALACTOSIDE DERIVATES
    5.
    发明申请
    GEM-DIFLUORINATED C-ISOPROPYLGALACTOSIDE DERIVATES 有权
    GEM-衍生的C-异丙基乳糖苷衍生物

    公开(公告)号:US20140199727A1

    公开(公告)日:2014-07-17

    申请号:US14237490

    申请日:2012-08-08

    IPC分类号: C12N15/63 C07H7/02 C12P21/00

    摘要: The present invention concerns compounds of the following formula (I) or a pharmaceutically acceptable salt thereof, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, in which R represents H, OH or OR19, as well as processes for preparing these compounds and their use as inducer for the transcription of genes under control of the lac promoter.

    摘要翻译: 本发明涉及下列通式(I)的化合物或其药学上可接受的盐,立体异构体或任何比例的立体异构体混合物,特别是对映体混合物,特别是外消旋物混合物,其中R代表H,OH 或OR19,以及制备这些化合物的方法及其作为诱导剂用于在lac启动子控制下转录基因的用途。